Patents by Inventor Michael Gumkowski

Michael Gumkowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
    Publication number: 20070282009
    Abstract: A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer.
    Type: Application
    Filed: April 30, 2007
    Publication date: December 6, 2007
    Inventors: Marshall Crew, William Curatolo, Dwayne Friesen, Michael Gumkowski, Douglas Lorenz, James Nightlingale, Roger Ruggeri, Ravi Shanker
  • Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers
    Publication number: 20060216351
    Abstract: In one aspect, pharmaceutical compositions comprising dispersions of an acid-sensitive drug and a neutral dispersion polymer are disclosed. The acid-sensitive drug has improved chemical stability relative to dispersions of the drug and acidic polymers. In another aspect, pharmaceutical compositions of low-solubility drugs and amphiphilic, hydroxy-functional vinyl copolymers are disclosed.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 28, 2006
    Inventors: Dwayne Friesen, Michael Gumkowski, Rodney Ketner, Douglas Lorenz, James Nightingale, Ravi Shanker, James West
  • Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor
    Publication number: 20060211654
    Abstract: A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer.
    Type: Application
    Filed: June 2, 2006
    Publication date: September 21, 2006
    Inventors: William Curatolo, Dwayne Friesen, Michael Gumkowski, Douglas Lorenz, James Nightingale, Roger Ruggeri, Ravi Shanker
  • Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
    Publication number: 20060014788
    Abstract: CETP Inhibitors have improved solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent, or a surfactant. Preferred such compositions are self-emulsifying or self-microemulsifying, and comprise 1. a CETP inhibitor; 2. a cosolvent; 3. a surfactant having an HLB of 1 to 8; 4. a surfactant having an HLB of over 8 to 20; and 5. optionally, a digestible oil.
    Type: Application
    Filed: September 8, 2005
    Publication date: January 19, 2006
    Inventors: Michael Gumkowski, Franco Lombardo, Sharad Murdande, Michael Perlman